CD4 and acute lymphoblastic leukemia: We have assessed the anti-tumor activity of NVP-BGT226 (BGT226), Torin-2, MK-2206 and ZSTK474 in human T-ALL cells and studied their effects on healthy CD4+ T-cell, induced or not to proliferate.